Low dose (2.0 GBq) radioiodine postsurgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low risk patients

被引：0
|
作者：
Chianelli, M. [1 ]
Todino, V. [1 ]
Graziano, F. [1 ]
Panunzi, C. [1 ]
Guglielmi, R. [1 ]
Signore, A. [2 ]
Papini, E. [1 ]
机构：
[1] Regina Apostolorum Hosp, Albano Rome, Italy
[2] St Andrea Hosp, Rome, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S344 / S344
页数：1
相关论文
共 50 条
  • [31] Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the “con” point of view
    Livia Lamartina
    David S. Cooper
    Endocrine, 2015, 50 : 67 - 71
  • [32] Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
    Lamartina, Livia
    Durante, Cosimo
    Filetti, Sebastiano
    Cooper, David S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (05): : 1748 - 1761
  • [33] Quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer
    Abdulrezzak, Ummuhan
    Tutus, Ahmet
    Isik, Ilknur
    Kurt, Yurdagul
    Kula, Mustafa
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (03): : 314 - 322
  • [34] Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen
    I. Borget
    H. Remy
    J. Chevalier
    M. Ricard
    M. Allyn
    M. Schlumberger
    G. De Pouvourville
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1457 - 1463
  • [35] Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen
    Borget, I.
    Remy, H.
    Chevalier, J.
    Ricard, M.
    Allyn, M.
    Schlumberger, M.
    De Pouvourville, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (08) : 1457 - 1463
  • [36] The quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer
    Abdulrezzak, U.
    Tutus, A.
    Kula, M.
    Kurt, Y.
    Kocaagaoglu, E.
    Sarikaya, Y.
    Isik, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S127 - S127
  • [37] Metastatic differentiated thyroid cancer in paediatric patients - radioiodine treatment after thyroid hormone withdrawal or rhTSH stimulation
    Handkiewicz-Junak, D.
    Kropinska, A.
    Ledwon, A.
    Roskosz, J.
    Kula, D.
    Kluczewska, A.
    Olczyk, T.
    Paliczka, E.
    Puch, Z.
    Jarzab, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S120 - S121
  • [38] Quality of Life and Effectiveness Comparisons of Thyroxine Withdrawal, Triiodothyronine Withdrawal, and Recombinant Thyroid-Stimulating Hormone Administration for Low-Dose Radioiodine Remnant Ablation of Differentiated Thyroid Carcinoma
    Lee, Jandee
    Yun, Mee Jin
    Nam, Kee Hyun
    Chung, Woong Youn
    Soh, Euy-Young
    Park, Cheong Soo
    THYROID, 2010, 20 (02) : 173 - 179
  • [39] Clinical Outcome of Low-risk Differentiated Thyroid Cancer Patients after Radioiodine Remnant Ablation and Recombinant Human Thyroid-stimulating Hormone Preparation
    Vianello, F.
    Mazzarotto, R.
    Mian, C.
    Lora, O.
    Saladini, G.
    Servodio, O.
    Basso, M.
    Pennelli, G.
    Pelizzo, M. R.
    Sotti, G.
    CLINICAL ONCOLOGY, 2012, 24 (03) : 162 - 168
  • [40] Prospective Study Confirms that Radioiodine Remnant Ablation Is Not Necessary in Low-Risk Differentiated Thyroid Cancer
    Pacini, Furio
    EUROPEAN THYROID JOURNAL, 2016, 5 (01) : 7 - +
12345